251 related articles for article (PubMed ID: 31605138)
21. Two-locus linkage analysis of cutaneous malignant melanoma/dysplastic nevi.
Goldstein AM; Goldin LR; Dracopoli NC; Clark WH; Tucker MA
Am J Hum Genet; 1996 May; 58(5):1050-6. PubMed ID: 8651266
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic FGFR1 mutation and amplification in common cellular origin in a composite tumor with neuroblastoma and pheochromocytoma.
Tasaka K; Ueno H; Yamasaki K; Okuno T; Isobe T; Kimura S; Umeda K; Hara J; Ogawa S; Takita J
Cancer Sci; 2022 Apr; 113(4):1535-1541. PubMed ID: 34971484
[TBL] [Abstract][Full Text] [Related]
23. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
[TBL] [Abstract][Full Text] [Related]
24. Environmental cues from neural crest derivatives act as metastatic triggers in an embryonic neuroblastoma model.
Ben Amar D; Thoinet K; Villalard B; Imbaud O; Costechareyre C; Jarrosson L; Reynaud F; Novion Ducassou J; Couté Y; Brunet JF; Combaret V; Corradini N; Delloye-Bourgeois C; Castellani V
Nat Commun; 2022 May; 13(1):2549. PubMed ID: 35538114
[TBL] [Abstract][Full Text] [Related]
25. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.
Goldstein AM; Dracopoli NC; Engelstein M; Fraser MC; Clark WH; Tucker MA
Am J Hum Genet; 1994 Mar; 54(3):489-96. PubMed ID: 8116618
[TBL] [Abstract][Full Text] [Related]
26. Suppression of neuroblastoma growth by dipeptidyl peptidase IV: relevance of chemokine regulation and caspase activation.
Arscott WT; LaBauve AE; May V; Wesley UV
Oncogene; 2009 Jan; 28(4):479-91. PubMed ID: 18978811
[TBL] [Abstract][Full Text] [Related]
27. Neuroblastoma stage 4S: a multifocal stem-cell disease of the developing neural crest.
van Noesel MM
Lancet Oncol; 2012 Mar; 13(3):229-30. PubMed ID: 22381931
[No Abstract] [Full Text] [Related]
28. Linkage analysis of extended high-risk pedigrees replicates a cutaneous malignant melanoma predisposition locus on chromosome 9q21.
Cannon-Albright LA; Teerlink CC; Farnham JM; Thomas AW; Zone JJ; Leachman SA
J Invest Dermatol; 2013 Jan; 133(1):128-34. PubMed ID: 22951724
[TBL] [Abstract][Full Text] [Related]
29. Integrative genomics identifies LMO1 as a neuroblastoma oncogene.
Wang K; Diskin SJ; Zhang H; Attiyeh EF; Winter C; Hou C; Schnepp RW; Diamond M; Bosse K; Mayes PA; Glessner J; Kim C; Frackelton E; Garris M; Wang Q; Glaberson W; Chiavacci R; Nguyen L; Jagannathan J; Saeki N; Sasaki H; Grant SF; Iolascon A; Mosse YP; Cole KA; Li H; Devoto M; McGrady PW; London WB; Capasso M; Rahman N; Hakonarson H; Maris JM
Nature; 2011 Jan; 469(7329):216-20. PubMed ID: 21124317
[TBL] [Abstract][Full Text] [Related]
30. Additional data support the role of
Li Y; Zhuo ZJ; Zhou H; Liu J; Liu Z; Zhang J; Cheng J; Li S; Zhou H; Zhou R; He J; Zhao Y
Aging (Albany NY); 2019 Apr; 11(8):2369-2377. PubMed ID: 31005956
[TBL] [Abstract][Full Text] [Related]
31. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma.
Howell WM; Turner SJ; Theaker JM; Bateman AC
Eur J Immunogenet; 2003 Dec; 30(6):409-14. PubMed ID: 14675394
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of developing cutaneous malignant melanoma is associated with variation in pigmentation genes and VDR, and may involve epistatic effects.
Kosiniak-Kamysz A; Marczakiewicz-Lustig A; Marcińska M; Skowron M; Wojas-Pelc A; Pośpiech E; Branicki W
Melanoma Res; 2014 Aug; 24(4):388-96. PubMed ID: 24926819
[TBL] [Abstract][Full Text] [Related]
33. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
Howell WM; Turner SJ; Bateman AC; Theaker JM
Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
[TBL] [Abstract][Full Text] [Related]
34. Ascl1 phospho-status regulates neuronal differentiation in a Xenopus developmental model of neuroblastoma.
Wylie LA; Hardwick LJ; Papkovskaia TD; Thiele CJ; Philpott A
Dis Model Mech; 2015 May; 8(5):429-41. PubMed ID: 25786414
[TBL] [Abstract][Full Text] [Related]
35. Common sequence variants on 20q11.22 confer melanoma susceptibility.
Brown KM; Macgregor S; Montgomery GW; Craig DW; Zhao ZZ; Iyadurai K; Henders AK; Homer N; Campbell MJ; Stark M; Thomas S; Schmid H; Holland EA; Gillanders EM; Duffy DL; Maskiell JA; Jetann J; Ferguson M; Stephan DA; Cust AE; Whiteman D; Green A; Olsson H; Puig S; Ghiorzo P; Hansson J; Demenais F; Goldstein AM; Gruis NA; Elder DE; Bishop JN; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Martin NG; Trent JM; Mann GJ; Hayward NK
Nat Genet; 2008 Jul; 40(7):838-40. PubMed ID: 18488026
[TBL] [Abstract][Full Text] [Related]
36. Recent advances in the developmental origin of neuroblastoma: an overview.
Ponzoni M; Bachetti T; Corrias MV; Brignole C; Pastorino F; Calarco E; Bensa V; Giusto E; Ceccherini I; Perri P
J Exp Clin Cancer Res; 2022 Mar; 41(1):92. PubMed ID: 35277192
[TBL] [Abstract][Full Text] [Related]
37. MYC-associated protein X binding with the variant rs72780850 in RNA helicase DEAD box 1 for susceptibility to neuroblastoma.
Jin Y; Shi J; Wang H; Lu J; Chen C; Yu Y; Wang Y; Yang Y; Ren D; Zeng Q; Ni X; Guo Y
Sci China Life Sci; 2021 Jun; 64(6):991-999. PubMed ID: 32915406
[TBL] [Abstract][Full Text] [Related]
38. PHOX2B mutations and genetic predisposition to neuroblastoma.
Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
[TBL] [Abstract][Full Text] [Related]
39. Identification of a melanoma susceptibility locus and somatic mutation in TET2.
Song F; Amos CI; Lee JE; Lian CG; Fang S; Liu H; MacGregor S; Iles MM; Law MH; Lindeman NI; Montgomery GW; Duffy DL; Cust AE; Jenkins MA; Whiteman DC; Kefford RF; Giles GG; Armstrong BK; Aitken JF; Hopper JL; Brown KM; Martin NG; Mann GJ; Bishop DT; Bishop JA; ; Kraft P; Qureshi AA; Kanetsky PA; Hayward NK; Hunter DJ; Wei Q; Han J
Carcinogenesis; 2014 Sep; 35(9):2097-101. PubMed ID: 24980573
[TBL] [Abstract][Full Text] [Related]
40. Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk.
Nan H; Xu M; Zhang J; Zhang M; Kraft P; Qureshi AA; Chen C; Guo Q; Hu FB; Rimm EB; Curhan G; Song Y; Amos CI; Wang LE; Lee JE; Wei Q; Hunter DJ; Han J
Hum Mol Genet; 2011 Jul; 20(13):2673-9. PubMed ID: 21478494
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
